News from the life sciences and technology communities north of Boston |
|
|
|
Governor Maura Healey signed an Executive Order establishing the Artificial Intelligence Strategic Task Force to study AI and Generative Artificial Intelligence (GenAI) technology and its impact on the Commonwealth, private businesses, higher education institutions, and constituents.
According to a press release, the mission of the task force is to create specific recommendations for how the Commonwealth can best support its businesses in leading sectors around AI adoption. It will also produce recommendations focused on startups’ ability to scale and succeed in Massachusetts. The Governor will seek $100 million in the upcoming Economic Development Bill to create an Applied AI Hub in Massachusetts. |
 |
|
Arnasi Group, formerly LiquiGlide, is the newest client to join the Cummings community at 12 Gill Street, Woburn. Arnasi is developing next-generation biomedical and consumer packaged goods products by leveraging proprietary technology to improve user experience and health outcomes for patient populations with best-in-class products.
Dave Smith is CTO and co-founder. He is has been recognized as a Forbes 30-under-30 honoree. |
Gloucester Marine Genomics Institute (GMGI), a North Shore nonprofit addressing critical challenges facing our oceans, human health, and the environment through innovative scientific research and education, announced the appointment of Dr. Andrew Gardner as the organization’s inaugural Chief Scientific Officer (CSO). Dr. Gardner brings an impressive track record of discovery, innovation, and team leadership after 28 years at New England Biolabs, in Ipswich, where he most recently served as scientific director of molecular enzymology. |
|
Myrobalan Therapeutics (200 Boston Ave., Medford), has received a $400,000 grant from the ALS Association to support the advancement of its colony-stimulating factor-1 receptor (CSF1R) inhibitor for the treatment of amyotrophic lateral sclerosis (ALS). The grant has been made through the Association’s Lawrence and Isabel Barnett Drug Development Program, supplementing the previously announced $24 million in Series A funding.
Jing Wang, Ph.D., is Myrobalan's CEO & co-founder |
|
|
|
Congratulations to Qiaobing Xu, Ph.D., scientific founder and chief technology officer of Hopewell Therapeutics (300 West Cummings Park, Woburn), on receiving project funding from the Healey-Driscoll Administration and the Massachusetts Life Sciences Center (MLSC). More than $11.5 million in funding has been announced to support 26 projects that are advancing innovation in therapeutic delivery and unlocking the potential of data science to answer pressing life sciences questions.
The MLSC Novel Therapeutics Delivery program aims to capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery. Dr. Xu's project is titled, "Brain delivery of mRNA using neurotransmitter derived lipid nanoparticles." |
 |
The 2024 Digital Equity Challenge is now open. Since 2022, the UMass Lowell Innovation Hub Haverhill has partnered with Essex County Community Foundation to annually present the Digital Equity Challenge. Individuals, students, and organizations are invited to apply to the challenge to win seed funding to launch or grow community-based, entrepreneurial solutions that address digital equity in Essex County. Learn more. |
|
|
|
A recent Wall Street Journal article examined the tight financing market for vaccine startups, and the gap that exists between federal funding for early-stage companies and the revenue that comes with contracts and corporate partnerships for late-stage enterprises.
Co-founder and CEO Michael Shrader of Vaxess Technologies (GMP facility at One Cummings Park, Woburn) offered his perspective on the funding environment and the need for more public and private investment in vaccine development. Read more in WSJ (subscription required). |
|
|
The next virtual BioXchange will be held Wednesday, February 21 from 4:00 to 7:00 PM. Founded in 2019 by Ed McNamara and Josh Lang, this free forum provides an opportunity to interact with individuals throughout the life sciences industry from all over the world. Register. |
|
|
Join North Shore Technology Council for a March Mixer and Membership Mania! Become a member of NSTC ($100 annually) and receive a free ticket to the mixer for you and a guest. Event tickets include food, two drink tickets, and a virtual reality presentation by PTC.
Thursday, March 14, 5:00 - 7:30 PM at Granite Coast Brewing, Peabody. Register. |
|
Save the date for the 2024 MassBio State of Possible conference, April 24 at Royal Sonesta Boston.
Attendees from the lab to the C-suite will experience engaging panel discussions on surviving biotech’s choppy waters and rewriting what is possible in science, a fireside chat on state and federal affairs, an inspiring keynote from three-time Super Bowl champion and sickle cell disease advocate Devin McCourty, and ample time for networking, partnering, and celebrating. |
|
|
925 to 4,400 SF Labs Available in Beverly |
|
Join the North Shore's largest lab cluster. With more than 80 life sciences and health technology firms, Cummings Center in Beverly offers a vibrant community of early-stage and established companies. Active on-site industry networking associations include MassBio and North Shore Technology Council.
Located 30 minutes from Boston, with public transportation available, Beverly is rated a Platium-level MassBio BioReady Community. |
|
These three suites at 100 Cummings Center can be leased together or separately, offering maximum flexibility based on your needs: |
|
|
|
Office Suite 243-C
2,450 SF |
|
Each lab suite offers:
- 8’ fume hood
- Make-up air and dedicated exhaust
- Lab sink with point-of-use acid neutralization tank
- Ample benchwork
- Eyewash station
- Double-door entry
- Vinyl-faced ceilings
- Epoxy-painted walls
|
|
|
|
We welcome your feedback on this newsletter and invite readers to share company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at svh@cummings.com to offer your news for upcoming newsletters. We look forward to hearing from you. |
|
|
|
|
